Winning Health Technology Group Co Ltd
SZSE:300253
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/GP
Enterprise Value to Gross Profit (EV/GP) ratio compares a company`s total enterprise value to its gross profit. It shows how much investors are paying for each dollar of the company`s gross profit, including both equity and debt.
Enterprise Value to Gross Profit (EV/GP) ratio compares a company`s total enterprise value to its gross profit. It shows how much investors are paying for each dollar of the company`s gross profit, including both equity and debt.
Valuation Scenarios
If EV/GP returns to its 3-Year Average (16.2), the stock would be worth ¥5.4 (37% downside from current price).
| Scenario | EV/GP Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 25.9 | ¥8.64 |
0%
|
| 3-Year Average | 16.2 | ¥5.4 |
-37%
|
| 5-Year Average | 17.3 | ¥5.77 |
-33%
|
| Industry Average | 8.4 | ¥2.81 |
-68%
|
| Country Average | 13.6 | ¥4.54 |
-48%
|
Forward EV/GP
Today’s price vs future gross profit
Peer Comparison
| Market Cap | EV/GP | P/E | ||||
|---|---|---|---|---|---|---|
| CN |
|
Winning Health Technology Group Co Ltd
SZSE:300253
|
19.1B CNY | 25.9 | -62.1 | |
| JP |
|
Medical Data Vision Co Ltd
TSE:3902
|
37.9T JPY | 13.6 | 227.5 | |
| US |
C
|
Cerner Corp
LSE:0R00
|
31.3B USD | 6.7 | 53.1 | |
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
28.1B USD | 8.9 | 30.9 | |
| AU |
|
Pro Medicus Ltd
ASX:PME
|
14.2B AUD | 56.4 | 60.6 | |
| JP |
|
M3 Inc
TSE:2413
|
1T JPY | 5 | 20.5 | |
| SE |
|
Sectra AB
STO:SECT B
|
49.2B SEK | 35.4 | 91.5 | |
| US |
|
Doximity Inc
NYSE:DOCS
|
4.6B USD | 6.8 | 19.3 | |
| US |
W
|
Waystar Holding Corp
NASDAQ:WAY
|
4B USD | 7.1 | 35 | |
| IN |
I
|
Inventurus Knowledge Solutions Ltd
NSE:IKS
|
283.9B INR | 9.4 | 42.8 | |
| US |
V
|
Vocera Communications Inc
F:V00
|
2.4B EUR | 17.3 | -328 |
Market Distribution
| Min | 0 |
| 30th Percentile | 8 |
| Median | 13.6 |
| 70th Percentile | 23.3 |
| Max | 17 898 541.1 |
Other Multiples
Winning Health Technology Group Co Ltd
Glance View
Winning Health Technology Group Co Ltd, a pioneer in digital health solutions, operates at the intersection of healthcare and technology, crafting innovative tools that transform the way medical services are delivered and managed. Established with a mission to enhance healthcare efficiency, the company specializes in providing comprehensive IT solutions for hospitals and medical institutions. Their suite of products spans from electronic medical records (EMRs) to hospital information systems (HIS), leveraging cloud computing and big data analytics to streamline operations and improve patient outcomes. By seamlessly integrating their technology into medical facilities, Winning Health empowers healthcare providers to deliver more precise, efficient, and personalized care. The company's revenue model is centered around software licensing, implementation services, and ongoing support and maintenance. Hospitals and medical centers invest in Winning Health’s solutions to modernize their systems, thus driving recurring revenues from software updates and technical support. Additionally, their expertise in leveraging data analytics provides healthcare organizations with actionable insights, enhancing diagnostic accuracy and resource management. As a result, Winning Health not only thrives on its software and IT solutions revenue streams, but also solidifies its position in the rapidly evolving health technology landscape by continuously innovating to meet the dynamic needs of the medical field.
